NASDAQ:EIGR
Eiger BioPharmaceuticals
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.eigerbio.comipo date
Jan 30, 2014
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infec...Show More
Earnings
Earnings Release in 16 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus